Analysis and Cut-off Adjustment of Dried Blood Spot 17alpha-hydroxyprogesterone Concentration by Birth Weight
![]() |
Park, Seungman
(Green Cross Laboratories)
Kwon, Aerin (Green Cross Laboratories) Yang, Songhyeon (Green Cross Laboratories) Park, Euna (Green Cross Laboratories) Choi, Jaehwang (Green Cross Laboratories) Hwang, Mijung (Green Cross Laboratories) Nam, Hyeongyeong (Green Cross Laboratories) Lee, Eunhee (Green Cross Laboratories) |
1 | White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-91. |
2 | Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-88. DOI ScienceOn |
3 | Miller WL, Levine LS. Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 1987;111:1-17. DOI |
4 | Klingensmith GJ, Garcia SC, Jones HW, Migeon CJ, Blizzard RM. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 1977;90:996-1004. DOI |
5 | Migeon CJ. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1990;70:836-7. DOI |
6 | Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab 1984;58:857-61. DOI |
7 | Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178-82. DOI ScienceOn |
8 | Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 2001;108:E68. DOI ScienceOn |
9 | Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 1997;130:128-33. DOI ScienceOn |
10 | Kang MS, Nahm CH, Choi JW, Jeon YH, Im MW, Lee CH, Pai SH. Analysis of Blood Spot 17-Hydroxyprogesterone Concentration According to Gestational Age and Birth Weight. Korean J Clin Pathol 2001;21:104-8. |
11 | Oh KI, Kim SJ, Kim DH, Kim JK, Jun YH, Choi JW, Lee JE. Revaluation of Neonatal Screening Test for Congenital Adrenal Hyperplasia. J Korean Soc Pediatr Endocrinol 2006;11:192-8. |
12 | Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants-proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Paediatr Jpn 1992;34:126-33. DOI ScienceOn |
13 | Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogestereone levels. J Pediatr 1997;130:128-33. DOI ScienceOn |
![]() |